Skip to main content
. 2020 Jun;61(6):850–856. doi: 10.2967/jnumed.119.233965

TABLE 1.

In Vitro Dosimetry

Parameter IMR-05 NLF
Mean D50 ± SEM (Gy)
 125I-KX1 0.18 ± 0.01 2.0 ± 0.1
 131I-KX1 0.35 ± 0.01 3.5 ± 0.3
 125I-MIBG 1.1 ± 0.1 3.7 ± 0.3
 211At-MM4 0.051 ± 0.002 0.56 ± 0.07
 211At-NaAtx 0.20 ± 0.01 1.0 ± 0.1
 External γ 0.71 ± 0.02 3.7 ± 0.1
RBE for nontargeted therapy
125I-MIBG vs. γ 0.65 1.0
211At-NaAtx vs. γ 3.6 3.7
211At-NaAtx vs. 125I-MIBG 5.5 3.7
RBE for targeted therapy
125I-KX1 vs. 131I-KX1 1.9 1.8
211At-MM4 vs. 131I-KX1 6.7 6.3
211At-MM4 vs. 125I-KX1 3.5 3.6